30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Bright Green Corp (BGXX)

Track

Stock chart
Ticker: BGXX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Elmasri Saleem
Chief Financial Officer
1 sale — total 2,520 USD
Sale 10 Sep 2024
Value US$803,396.72 | Price 96.78 | Shares 46,564
Sale 9 Sep 2024
Value US$3,448,448.60 | Price 346.80 | Shares 67,289
Proposed sale 9 Sep 2024
Value US$93,863.22 | Price 0.19 | Shares 489,636
Sale 6 Sep 2024
Value US$2,848.07 | Price 0.20 | Shares 14,598
Proposed sale 6 Sep 2024
Value US$2,848.07 | Price 0.20 | Shares 14,598
Sale 5 Sep 2024
Value US$11,465.08 | Price 0.20 | Shares 57,211
Proposed sale 5 Sep 2024
Value US$11,465.08 | Price 0.20 | Shares 57,211
Proposed sale 4 Sep 2024
Value US$19,604.49 | Price 0.20 | Shares 97,778
Sale 3 Sep 2024
Value US$80,950.92 | Price 0.20 | Shares 398,773
Proposed sale 3 Sep 2024
Value US$61,342.78 | Price 0.20 | Shares 300,995
Sale 5 Jun 2024
Value US$359,700.00 | Price 0.36 | Shares 1,000,000
Buy 10 Sep 2023
Value US$0.00 | Price 0.00 | Shares 500,000
Sale 31 Aug 2023
Value US$116,675.00 | Price 0.47 | Shares 250,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-11 2024-09-10 S Sale
3.9
Elmasri Saleem

Chief Financial Officer

Officer
46,564 +15.9%
96.78
US$803,397 		46,564 +15.9% 96.78 US$803,397
2024-09-11 2024-09-09 S Sale
3.9
Elmasri Saleem

Chief Financial Officer

Officer
67,289 +34.6%
346.80
US$3,448,449 		67,289 +34.6% 346.80 US$3,448,449
2024-09-09 2024-09-09 PrS Proposed sale
3.9
SALEEM C ELMASRI

Officer

Officer
73,188
143.96
US$1,297,928 		73,188 143.96 US$1,297,928
2024-09-10 2024-09-06 S Sale
3.9
Elmasri Saleem

Chief Financial Officer

Officer
14,598 -1.3%
0.20
US$2,848 		14,598 -1.3% 0.20 US$2,848
2024-09-06 2024-09-06 PrS Proposed sale
3.9
SALEEM C ELMASRI

Officer

Officer
14,598
0.20
US$2,848 		14,598 0.20 US$2,848
2024-09-10 2024-09-05 S Sale
3.9
Elmasri Saleem

Chief Financial Officer

Officer
57,211 -4.8%
0.20
US$11,465 		57,211 -4.8% 0.20 US$11,465
2024-09-05 2024-09-05 PrS Proposed sale
3.9
SALEEM C ELMASRI

Officer

Officer
57,211
0.20
US$11,465 		57,211 0.20 US$11,465
2024-09-04 2024-09-04 PrS Proposed sale
3.9
SALEEM C ELMASRI

Officer

Officer
97,778
0.20
US$19,604 		97,778 0.20 US$19,604
2024-09-05 2024-09-03 S Sale
3.9
Elmasri Saleem

Chief Financial Officer

Officer
398,773 -24.9%
0.20
US$80,951 		398,773 -24.9% 0.20 US$80,951
2024-09-03 2024-09-03 PrS Proposed sale
3.9
SALEEM C ELMASRI

Officer

Officer
300,995
0.20
US$61,343 		300,995 0.20 US$61,343
2024-06-10 2024-06-05 S Sale
3.8
Stockwell Lynn
Non-Executive Director Large shareholder
1,000,000 -1.4%
0.36
US$359,700 		1,000,000 -1.4% 0.36 US$359,700
2023-09-12 2023-09-10 B Purchase
3.9
Elmasri Saleem

CFO

Officer
500,000
0.00
US$0 		500,000 0.00 US$0
2023-09-06 2023-08-31 S Sale
3.8
Stockwell Lynn
Non-Executive Director Large shareholder
250,000 -0.4%
0.47
US$116,675 		250,000 -0.4% 0.47 US$116,675
Explore more

More insider trading research around Bright Green Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America